Ricerca avanzata

Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2005 Settembre;17(3) > Minerva Biotecnologica 2005 Settembre;17(3):127-31

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOMINERVA BIOTECNOLOGICA

Rivista di Biologia Molecolare e Biotecnologie


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246

 

Minerva Biotecnologica 2005 Settembre;17(3):127-31

MEDICINAL PLANTS FOR BIOTECHNOLOGY AND BIOMEDICINE 

The role of metabolic engineering for the production of secondary metabolites of plants

Khan M. T. H. 1, 2, Ather A. 2, Gambari R. 2, 3

1 Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, University of Science and Technology, Chittagong, Bangladesh;
2 ER-GenTech, Department of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy;
3 Biotechnology Center, University of Ferrara, Ferrara, Italy

Plants are very interesting and useful sources of molecules of great importance for the development of new pharmaceutical products. Metabolic engineering has proven to be a valuable tool for large production of several biomedically as well as industrially relevant compounds from micro-organisms as well from higher plants. Current development of studies employing transgenic and/or recombinant technologies have opened up opportunities of the metabolic engineering/ metabolo-mics of biosynthetic pathways, leading to the growth of manufacturing of high-value secondary metabolites, even at the commercial level.

lingua: Inglese


Full text temporaneamente non disponibile on-line. Contattaci  ESTRATTI

inizio pagina